Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

191
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
191
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

156
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

362
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
362
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

115
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
115
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

246
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
246
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

992
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
992

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Artificial Intelligence hallucinating?

Turk psikiyatri dergisi = Turkish journal of psychiatry·2024
Same author

How to mitigate the risks of deployment of artificial intelligence in medicine?

Turkish journal of medical sciences·2024
Same author

Reproducible machine learning research in mental workload classification using EEG.

Frontiers in neuroergonomics·2024
Same author

Effect of hydrogen sulfide on ischemia-reperfusion injury of kidney: A systematic review and meta-analysis of in vivo animal studies.

European journal of pharmacology·2023
Same author

Turkey's transition to face-to-face schooling during the COVID-19 pandemic.

Turkish journal of medical sciences·2022
Same author

PToPI: A Comprehensive Review, Analysis, and Knowledge Representation of Binary Classification Performance Measures/Metrics.

SN computer science·2022
Same journal

An Ultra-Lightweight Cross-scale Attention Mamba Network for Accurate Skin Lesion Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Explanation-Guided Reconstruction of Missing Clinical Features for Survival Prediction in Pancreatic Cancer.

IEEE journal of biomedical and health informatics·2026
Same journal

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same journal

Patient-specific Biomechanical Investigation of Percutaneous Pulmonary Valves: Towards the Integration of Routinely Acquired Clinical Data and Fluid-structure Interaction Simulations.

IEEE journal of biomedical and health informatics·2026
Same journal

Cross-subject fMRI-to-Image with Visual-cortex 2D Representation and Pre-Training.

IEEE journal of biomedical and health informatics·2026
Same journal

PGCASurv: A Prior-Guided Cross-Attention Framework for Dynamic Survival Model with Longitudinal Data.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

A Bayesian Estimation Framework for Pharmacogenomics Driven Warfarin Dosing: A Comparative Study.

Serdar Murat Öztaner, Tuğba Taşkaya Temizel, S Remzi Erdem

    IEEE Journal of Biomedical and Health Informatics
    |July 15, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Pharmacogenomics improves drug dosing accuracy and reduces adverse effects. A novel Bayesian structural equation model enhances warfarin dosing predictions compared to linear models.

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K

    Area of Science:

    • Pharmacogenomics
    • Computational Biology
    • Clinical Pharmacology

    Background:

    • Pharmacogenomics integration enhances drug dosing accuracy.
    • Reduces adverse drug events.
    • Warfarin dosing variability is a clinical challenge.

    Purpose of the Study:

    • Propose a novel pharmacogenomics-driven estimation framework.
    • Utilize Bayesian structural equation modeling (Bayesian SEM).
    • Improve warfarin dosing prediction accuracy.

    Main Methods:

    • Developed a Bayesian SEM framework.
    • Incorporated pharmacogenomics data.
    • Compared model performance against linear models for warfarin dosing.

    Main Results:

    • The proposed Bayesian SEM framework shows favorable prediction accuracy.
    • The model effectively explains variations in warfarin dosing.
    • Outperforms traditional linear models in prediction and explanatory power.

    Conclusions:

    • Pharmacogenomics-driven Bayesian SEM is effective for drug dosing.
    • This approach enhances warfarin dosing precision.
    • Offers a promising method for personalized medicine.